Simply Oncology

Send us Fan Mail

We return for part 2 of our overview on metastatic oesphago-gastric cancer.

Join us as we welcome back Dr Lizzy Smyth from Oxford University Hospitals.

We look at the importance of nutritional support.

We discuss future directions such as CAR-T therapy

Lizzy mocks John (again!!)

A brilliant finish to our OG masterclass from Lizzy.

Enjoy!

Send us Fan Mail

Dr Lizzie Smyth from Oxford University Hospitals gives us a an amazing 2 part overview of management of metastatic Oesophago-Gastric cancer.

We discuss molecular testing and therapy options in metastatic OG cancer🧬
HER2
PDL 1
Claudin 18.2

Lizzy is a hugely respected figure in OG cancer and key clinical trialist!

John gets put in his place by Lizzy on several occasions!!

Lizzy has a way of describing things that even John could understand!!

Part 1 of 2 in this metastatic OG masterclass.

Enjoy!

Send us Fan Mail

Happy New Year!!!

WE return in 2026 to complete our overview of PARPi in prostate cancer with the peerless Professor Rob Jones.

Send us Fan Mail

Join us as we unwind in the Christmas Holiday period with a masterful overview of PARP inhibitors in metastatic prostate cancer with Professor Rob Jones.

Rob is an old friend of the show and is amazing at setting the scene for who & when PARP inhibitors can be useful in metastatic prostate cancer.

Send us Fan Mail

Welcome back!

In part 1 we discussed the major effects of menopause and how these can be worsened by hormonal medications given to treat breast cancer and the impact these can have on patients completing treatment as planned.

In this episode we welcome back Dr Rebecca Bowen and discuss practical advice on managing these symptoms including a link to what will be a vital resource for all clinicians in Oncology and Primary Care: the Meno.Pause app.

Link below, download today!

Meno.Pause App 

We wish all our wonderful listeners and guests a very Merry Christmas, thank you as always for tuning in,

John and Mike.

Send us Fan Mail

When is it safe to giving HRT in women who are being treated or have previously been diagnosed with breast cancer?

Will the use of vaginal oestrogens affect breast cancer outcomes?

What is the trade off on quality of life when symptoms of the menopause aren't managed?

Did you know that roughly 1 in 4 women stop their hormone therapy for breast cancer due to menopausal side effects!!

Who better to answer these questions and more than Dr Rebecca Bowen, Consultant Oncologist in Royal University Hospitals Bath who specialises in the treatment of breast and gynaecological cancers and heads up the specialist cancer and menopause unit. 

Send us Fan Mail

Sexual health in cancer is a topic we need to talk more about.

So many patients feel unable to  discuss their sexual health and also clinical teams don’t also mange to bring the topic up.

A cancer diagnosis can affect self image and confidence.

We talk to Lorraine Grover who is a sexual health specialist nurse about how we can break down some of these barriers.

Erectile dysfunction and much more discussed.

You may never look at a Calypo ice lolly the same again !!

This episode does contain some adult themes.

Send us Fan Mail

We return to Part 2 of our walk through metastatic bowel cancer with the excellent Professor Naureen Starling.

We look at RAS, BRAF and future directions for treatment of metastatic bowel cancer.

Can ctDNA have a role in metastatic bowel cancer?

What role may HER2 have to play going forward?

What is exciting on the horizon in mCRC?

Enjoy!!

Send us Fan Mail

Send us Fan Mail

Join us as we return for Part 2 with the superb Dr Alison Berner.

It’s Transgender Awareness Week and we discuss resources to support patients and clinicians.

We discuss OUTpatients and UCATS - UK cancer and transition service.